296 related articles for article (PubMed ID: 17604997)
1. Developing pharmacological therapies for Alzheimer disease.
Iqbal K; Grundke-Iqbal I
Cell Mol Life Sci; 2007 Sep; 64(17):2234-44. PubMed ID: 17604997
[TBL] [Abstract][Full Text] [Related]
2. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
Iqbal K; Grundke-Iqbal I
J Cell Mol Med; 2008; 12(1):38-55. PubMed ID: 18194444
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological approaches of neurofibrillary degeneration.
Iqbal K; Grundke-Iqbal I
Curr Alzheimer Res; 2005 Jul; 2(3):335-41. PubMed ID: 15974899
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tanimukai H; Tsujio I; Wang JZ; Grundke-Iqba I
J Mol Neurosci; 2003; 20(3):425-9. PubMed ID: 14501027
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Tsujio I; Grundke-Iqbal I
J Neural Transm Suppl; 2002; (62):309-19. PubMed ID: 12456074
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of tau-induced neurodegeneration.
Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
Iqbal K; Alonso AD; Gondal JA; Gong CX; Haque N; Khatoon S; Sengupta A; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 2000; 59():213-22. PubMed ID: 10961432
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.
Gong CX; Iqbal K
Curr Med Chem; 2008; 15(23):2321-8. PubMed ID: 18855662
[TBL] [Abstract][Full Text] [Related]
11. Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tsujio I; Wang JZ; Grundke-Iqbal I
J Mol Neurosci; 2002; 19(1-2):95-9. PubMed ID: 12212801
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
13. Tau pathology in Alzheimer disease and other tauopathies.
Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
[TBL] [Abstract][Full Text] [Related]
14. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial.
Iqbal K; Wang X; Blanchard J; Liu F; Gong CX; Grundke-Iqbal I
Biochem Soc Trans; 2010 Aug; 38(4):962-6. PubMed ID: 20658985
[TBL] [Abstract][Full Text] [Related]
16. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
[TBL] [Abstract][Full Text] [Related]
17. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
[TBL] [Abstract][Full Text] [Related]
18. Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective.
Iqbal K; Grundke-Iqbal I
J Alzheimers Dis; 2006; 9(3 Suppl):219-42. PubMed ID: 16914861
[TBL] [Abstract][Full Text] [Related]
19. Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease.
Iqbal K; Gong CX; Liu F
Expert Opin Ther Targets; 2014 Mar; 18(3):307-18. PubMed ID: 24387228
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathies.
Iqbal K; Grundke-Iqbal I
Curr Drug Targets; 2004 Aug; 5(6):495-502. PubMed ID: 15270196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
